Literature DB >> 25800118

Cognitive control and schizophrenia: The greatest reliability of the Stroop task.

Charlotte Laurenson1, Philip Gorwood2, Manuel Orsat3, Jean-Paul Lhuillier4, Didier Le Gall1, Stéphane Richard-Devantoy5.   

Abstract

Three components of cognitive inhibition were compared in patients with schizophrenia and healthy controls. Nineteen patients with schizophrenia were compared to 30 healthy controls, matched for age, sex, and educational level. Cognitive inhibition was examined by (i) access to relevant information (Reading with distraction task), (ii) suppression of no longer relevant information (Trail Making Test B), and (iii) restraint of cognitive resources to relevant information (Stroop Test, Hayling Sentence Completion Test, Go/No-Go Test). Beck Depression Inventory, and Positive and Negative Syndrome Scale were also used. Compared to healthy controls, patients with schizophrenia and stabilized for at least 6 months were slower in the inhibition condition at the Stroop task, read more distractors at the RWD, and made more perseverative errors at the TMT, even after controlling for age, Mini-Mental State Examination score, information speed processing, and accuracy. This difference remained significant after taking into account the level of depressive symptoms and the severity of psychotic symptoms. In multivariate analyses, only the Stroop interference index explained cognitive inhibition deficit in patients with schizophrenia. The abnormal cognitive inhibition process observed in patients with schizophrenia could therefore concerns the ability to restraint, rather than the access or the suppression processes.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cognition; Cognitive inhibition; Schizophrenia; Stroop

Mesh:

Year:  2015        PMID: 25800118     DOI: 10.1016/j.psychres.2015.03.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  What is the optimal neuropsychological test battery for schizophrenia in China?

Authors:  Chuan Shi; Lan Kang; Shuqiao Yao; Yibin Ma; Tao Li; Ying Liang; Zhang Cheng; Yifeng Xu; Jianguo Shi; Xiufeng Xu; Congpei Zhang; Donald R Franklin; Robert K Heaton; Hua Jin; Xin Yu
Journal:  Schizophr Res       Date:  2019-02-01       Impact factor: 4.939

2.  Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition.

Authors:  Ning-Bo Yang; Qing Tian; Yu Fan; Qi-Jing Bo; Liang Zhang; Liang Li; Chuan-Yue Wang
Journal:  BMC Psychiatry       Date:  2017-04-11       Impact factor: 3.630

3.  Prepulse inhibition in patients with bipolar disorder: a systematic review and meta-analysis.

Authors:  Zhen Mao; Qijing Bo; Weidi Li; Zhimin Wang; Xin Ma; Chuanyue Wang
Journal:  BMC Psychiatry       Date:  2019-09-11       Impact factor: 3.630

Review 4.  Cognition and Related Neural Findings on Methamphetamine Use Disorder: Insights and Treatment Implications From Schizophrenia Research.

Authors:  Alexandre A Guerin; Yvonne Bonomo; Andrew John Lawrence; Bernhard Theodor Baune; Eric J Nestler; Susan L Rossell; Jee Hyun Kim
Journal:  Front Psychiatry       Date:  2019-12-17       Impact factor: 4.157

5.  Involvement of amygdala-prefrontal dysfunction in the influence of negative emotion on the resolution of cognitive conflict in patients with schizophrenia.

Authors:  Jaesub Park; Ji-Won Chun; Hae-Jeong Park; Eosu Kim; Jae-Jin Kim
Journal:  Brain Behav       Date:  2018-07-13       Impact factor: 2.708

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.